不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression.
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的数据提供了特定免疫细胞亚群在 BL 早期阶段可能发挥作用的体内图像,这些细胞亚群可能能够维持肿瘤处于自限状态或诱导其消退。这些新结果可能为细胞免疫治疗时代 EBV 阳性 BL 患者提供新的潜在治疗途径的见解。
Burkitt淋巴瘤(BL)是一种侵袭性B细胞淋巴瘤,在某些情况下,可能表现出与良好预后和偶发自发消退相关的肉芽肿反应。在本研究中,我们旨在定义四例此类病例的肿瘤微环境(TME),其中两例自发消退。
所有病例均显示具有典型形态学、分子细胞遗传学和免疫表型的BL肿瘤细胞聚集,周围环绕着旺盛的上皮样肉芽肿反应。所有四例均为Epstein-Barr病毒(EBV)阳性,呈I型潜伏期。对TME的研究显示,四例病例具有相似的特征。分析揭示了由Th1淋巴细胞和M1极化巨噬细胞触发的促炎反应,这些细胞以特殊的地形分布环绕在肿瘤细胞周围。
AIMS: Burkitt lymphoma (BL) is an aggressive B-cell lymphoma that, in some instances, may show a granulomatous reaction associated with a favourable prognosis and occasional spontaneous regression. In the present study, we aimed to define the tumour microenvironment (TME) in four such cases, two of which regressed spontaneously. METHODS AND RESULTS: All cases showed aggregates of tumour cells with the typical morphology, molecular cytogenetics and immunophenotype of BL surrounded by a florid epithelioid granulomatous reaction. All four cases were Epstein-Barr virus (EBV)-positive with type I latency. Investigation of the TME showed similar features in all four cases. The analysis revealed a proinflammatory response triggered by Th1 lymphocytes and M1 polarised macrophages encircling the neoplastic cells with a peculiar topographic distribution. CONCLUSIONS: Our data provide an in-vivo picture of the role that specific immune cell subsets might play during the early phase of BL, which may be capable of maintaining the tumour in a self-limited state or inducing its regression. These novel results may provide insights into new potential therapeutic avenues in EBV-positive BL patients in the era of cellular immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。